Friday, 31 March 2017

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

(Reuters) - A U.S. patent board on Friday ruled against Danish drugmaker Forward Pharma A/S, finding Biogen's patents on its blockbuster multiple sclerosis drug Tecfidera to be valid.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)